The research proposal we have tabled with the industry to test 1,000 animals to validate the third-eyelid test has a parallel component, which is to do genetic susceptibility on those sheep as well.

74. Considers that the submission of a Commission report to the European Parliament and the Council on the influence of genetic parameters on the welfare of broiler breeders and broiler chickens by 2010 must be accompanied by appropriate legislative proposals;

72. Considers that the submission of a report to the European Parliament and the Council on the influence of genetic parameters on the welfare of broiler breeders and broiler chickens, for 2010, should be accompanied by appropriate legislative proposals;

The existing model that they opted to use—along with existing legislation, I might add—was one in which the comparison of a GM product with its source material, the material from which it was derived, would be a good starting point on which to base their analysis.

43. Notes that the growing tendency to gather genetic data highlights the problem posed by the spread of monitoring and control policies made possible by the different technologies; policies whereby genetic information is appropriated for private use cannot be considered admissible, even when they are accompanied by nominal guarantees to the effect that the rights of the persons concerned would be respected because the data would remain anonymous; it is becoming essential to lay down an institutional framework to enable access to tests to be geared to genuine health protection requirements and prevent the existing rules from being circ ...[+++]umvented via direct access to tests which bypasses the need for information based on genetic counselling;

13. Considers it essential, in order to make for a safe, beneficial, and responsible outcome in the new biomedical research, to lay down a harmonised regulatory framework to be recognised in all parts of Europe, providing for clear-cut rules focusing not just on development, but also on scientific and technological procedures, including guidelines on good laboratory, clinical, and industrial practice geared to the latest biomedical trends; calls on the Commission to review current practices in Member States which provide for the heterogeneity of genetic testing;